Intravenous Alteplase for Mild Nondisabling Acute Ischemic Stroke: A Bridge Too Far?

The author comments on a study published within the issue which focuses on a trial comparing intravenous alteplase and aspirin in terms of managing acute ischemic stroke. The author discusses the profiles of the patients who have demonstrated reduced disability after being treated with intravenous alteplase and analyzes its pros and cons for various types of patients. He also talks about the types of patients who will be better off being treated with aspirin instead of intravenous alteplase.